✦ LIBER ✦

ANCA-Associated Small Vessel Vasculitis: Clinical and Therapeutic Advances

✍ Scribed by Niveditha Mohan; Gail S. Kerr

Book ID: 107554186
Publisher: Springer
Year: 2010
Tongue: English
Weight: 155 KB
Volume: 12
Category: Article
ISSN: 1523-3774
DOI: 10.1007/s11926-010-0137-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pathophysiology of ANCA-Associated Small

Pathophysiology of ANCA-Associated Small Vessel Vasculitis

✍ Cees G. M. Kallenberg 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 260 KB

Classification of clinical subtypes, pat

Classification of clinical subtypes, patient survival, kidney prognosis, and relapse in patients with MPO-ANCA-associated vasculitis: a single-center experience

✍ Kimimasa Nakabayashi; Yoshihiro Arimura; Ken Yoshihara; Toshihiro Fukuoka; Miho 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 227 KB

Predictors of treatment resistance and r

Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody–associated small-vessel vasculitis: Comparison of two independent cohorts

✍ Christian Pagnoux; Susan L. Hogan; Hyunsook Chin; J. Charles Jennette; Ronald J. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB 👁 1 views

Development and initial evaluation of a

Development and initial evaluation of a measure of self-management for adults with antineutrophil cytoplasmic antibody-associated small-vessel vasculitis

✍ Thorpe, Carolyn T. ;Devellis, Robert F. ;Lewis, Megan A. ;Blalock, Susan J. ;Hog 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Associations of ABCB1, ABCC2, and ABCG2

Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer

✍ Ji-Youn Han; Hyeong-Seok Lim; Yeon-Kyeong Yoo; Eun Soon Shin; Yong Hoon Park; Su 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

## Abstract ## BACKGROUND. The authors investigated whether __ABCB1, ABCC2,__ and __ABCG2__ genetic polymorphisms affect pharmacokinetics (PK) of irinotecan and treatment outcome of patients with advanced nonsmall cell lung cancer (NSCLC). ## METHODS. Blood samples from 107 NSCLC patients treate

Erratum: Associations of ABCB1, ABCC2, a

Erratum: Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer

✍ Ji-Youn Han; Hyeong-Seok Lim; Yeon-Kyeong Yoo; Eun Soon Shin; Yong Hoon Park; Su 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 1 views